These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19939367)

  • 21. Young women with poor ovarian response exhibit epigenetic age acceleration based on evaluation of white blood cells using a DNA methylation-derived age prediction model.
    Hanson BM; Tao X; Zhan Y; Jenkins TG; Morin SJ; Scott RT; Seli EU
    Hum Reprod; 2020 Nov; 35(11):2579-2588. PubMed ID: 33049778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome.
    Kokosar M; Benrick A; Perfilyev A; Fornes R; Nilsson E; Maliqueo M; Behre CJ; Sazonova A; Ohlsson C; Ling C; Stener-Victorin E
    Sci Rep; 2016 Mar; 6():22883. PubMed ID: 26975253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys.
    Xu N; Kwon S; Abbott DH; Geller DH; Dumesic DA; Azziz R; Guo X; Goodarzi MO
    PLoS One; 2011; 6(11):e27286. PubMed ID: 22076147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis.
    Pan JX; Tan YJ; Wang FF; Hou NN; Xiang YQ; Zhang JY; Liu Y; Qu F; Meng Q; Xu J; Sheng JZ; Huang HF
    Clin Epigenetics; 2018; 10():6. PubMed ID: 29344314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity.
    Jones MR; Brower MA; Xu N; Cui J; Mengesha E; Chen YD; Taylor KD; Azziz R; Goodarzi MO
    PLoS Genet; 2015 Aug; 11(8):e1005455. PubMed ID: 26305227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation associated with polycystic ovary syndrome: a systematic review.
    Miranda AG; Seneda MM; Faustino LR
    Arch Gynecol Obstet; 2024 Feb; 309(2):373-383. PubMed ID: 37119419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylome and transcriptome profiling revealed epigenetic silencing of LPCAT1 and PCYT1A associated with lipidome alterations in polycystic ovary syndrome.
    Mao Z; Li T; Zhao H; Wang X; Kang Y; Kang Y
    J Cell Physiol; 2021 Sep; 236(9):6362-6375. PubMed ID: 33521992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter methylation of CYP19A1 gene in Chinese polycystic ovary syndrome patients.
    Yu YY; Sun CX; Liu YK; Li Y; Wang L; Zhang W
    Gynecol Obstet Invest; 2013; 76(4):209-13. PubMed ID: 24157654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of genomic DNA methylation in PCOS pathogenesis: a systematic review and meta-analysis involving case-controlled clinical studies.
    Rawat K; Sandhu A; Gautam V; Saha PK; Saha L
    Mol Hum Reprod; 2022 Jul; 28(8):. PubMed ID: 35789386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deciphering the DNA Methylome of Polycystic Ovary Syndrome.
    Tan Q
    Mol Diagn Ther; 2020 Jun; 24(3):245-250. PubMed ID: 32297305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS).
    Zhong X; Jin F; Huang C; Du M; Gao M; Wei X
    Technol Health Care; 2021; 29(S1):11-25. PubMed ID: 33682741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome.
    Chen Y; Wang G; Chen J; Wang C; Dong X; Chang HM; Yuan S; Zhao Y; Mu L
    Endocr Rev; 2024 Jul; 45(4):437-459. PubMed ID: 38298137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.
    Jiang LL; Xie JK; Cui JQ; Wei D; Yin BL; Zhang YN; Chen YH; Han X; Wang Q; Zhang CL
    Medicine (Baltimore); 2017 Jan; 96(2):e5768. PubMed ID: 28079802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic Ovarian Syndrome Genetics and Epigenetics.
    Combs JC; Hill MJ; Decherney AH
    Clin Obstet Gynecol; 2021 Mar; 64(1):20-25. PubMed ID: 33306497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women.
    Li S; Zhu D; Duan H; Ren A; Glintborg D; Andersen M; Skov V; Thomassen M; Kruse T; Tan Q
    Oncotarget; 2017 Mar; 8(13):20656-20666. PubMed ID: 27192117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer.
    Jiao J; Sagnelli M; Shi B; Fang Y; Shen Z; Tang T; Dong B; Li D; Wang X
    BMC Endocr Disord; 2019 Mar; 19(1):30. PubMed ID: 30866919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic and epigenetic factors of polycystic ovary syndrome].
    Herczeg Z; Vanya M; Szili K; Dézsi C; Nagy Z; Szabó J
    Orv Hetil; 2016 Aug; 157(32):1275-81. PubMed ID: 27499286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations.
    Li S; Zhu D; Duan H; Tan Q
    Gynecol Endocrinol; 2016 Dec; 32(12):942-946. PubMed ID: 27425146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
    Zhu JQ; Zhu L; Liang XW; Xing FQ; Schatten H; Sun QY
    Mol Hum Reprod; 2010 Apr; 16(4):260-6. PubMed ID: 19828691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.